Christopher J Jolles Md Onc is categorized under Doctors in Herriman, UT and active since 1994.
Christopher J Jolles Md Onc was established in 1994, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Christopher J Jolles at the company’s single location by writing to 12391 South 4000 West # 208, Herriman, Utah UT 84096 or by phoning (801) 302-5360. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Christopher J Jolles Md Onc |
| Contact Person: | Christopher J Jolles |
| Address: | 12391 South 4000 West # 208, Herriman, Utah 84096 |
| Phone Number: | (801) 302-5360 |
| Website Address: | specialgyo.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1994 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Christopher J Jolles Md Onc was started in 1994 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Christopher J Jolles for inquiries that concern Christopher J Jolles Md Onc by calling the company number (801) 302-5360, as your correspondence is most welcome. Additionally, the physical location of the single location of Christopher J Jolles Md Onc can be found at the coordinates 40.525857,-111.98602 as well as the street address 12391 South 4000 West # 208 in Herriman, Utah 84096.
For its online presence, you may visit Christopher J Jolles Md Onc’s website at specialgyo.com and engage with its social media outlets through on Twitter and on Facebook.